185 followers
#ResearchSpotlight: Tumour mutation burden has emerged as a crucial biomarker for ICI efficacy, yet its stability across different EBUS tumour regions remains unclear in advanced lung cancer patients. Leong & Aloe explored intertumoural TMB heterogenei